Fund Holdings — Flagship Pioneering Inc.

Total Portfolio Value
$843.36M
Total Bought
$0
Total Sold
$507.95M
Net Transaction
-$507.95M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Syros Pharmaceuticals Inc1,293,8491,293,84906,9226,6760.79%-246
Seres Therapeutics Inc(MCRB)23,117,04523,117,045017,89516,7321.98%-1,163
Foghorn Therapeutics Inc(FHTX)12,674,12012,674,120085,04372,8768.64%-12,167
Denali Therapeutics Inc(DNLI)1,364,5160-1,364,51628,0000—-28,000
Omega Therapeutics Inc29,225,57929,225,5790106,67360,4977.17%-46,176
Sana Biotechnology Inc(SANA)25,001,85625,001,8560250,019136,51016.19%-113,508
Moderna Inc(MRNA)9,666,0384,632,149-5,033,8891,030,013550,06865.22%-479,945
Page 1 of 1